Our Investments

Exited Investments
All
Active Investments
Exited Investments
All Funds
All Funds
415 Capital Fund I
CardioVentures
All Sectors
All Sectors
Aortic and Peripheral
Heart Failure
Hypertension
Medical Imaging
Medical Robotics
Neuromodulation
Neurovascular
Other
Patient Monitoring
Structural Heart

Laza Medical

AI-powered cardiovascular robotics and imaging solutions to improve clinical workflows in structural heart and electrophysiology procedures

Active

Supira Medical

Clinical-stage company developing a low-profile, high continuous flow percutaneous ventricular assist device (pVAD) for high-risk PCI and cardiogenic shock patients

Active

R3 Vascular

Clinical-stage company developing a world-class bioresorbable vascular scaffold technology for patients with peripheral vascular disease

Active

Moray Medical

R&D-stage company developing an innovative robotic catheter platform to enable minimally-invasive cardiovascular procedures

Active

CorFlow

Clinical-stage company developing the first system for both accurate detection and targeted therapy of microvascular obstruction (MVO)

Active

Cardiac Success

Clinical-stage company, developing a minimally invasive transcatheter device to repair and reshape the left ventricle in patients with Heart Failure with reduced Ejection Fraction (HFrEF)

Active

Aktiia

Commercial-stage company pioneering new ways to track, analyze and optimize blood pressure control, enabling physicians to deliver more targeted and timely care

Active

Distalmotion

Commercial-stage company pioneering on-demand surgical robotics. The company’s Dexter robotic platform allows hospitals and surgeons to benefit from the best of all worlds in surgical robotics and laparoscopy

Active

TRiCares

Clinical-stage company developing a minimally invasive transcatheter technology to replace the tricuspid valve in patients suffering from Tricuspid Regurgitation (TR)

Active

Vesper Medical

Developer of peripheral vascular products acquired by Royal Phillips (NYSE: PHG) in 2021

Exit

CoRRect Medical

Medical device distributor acquired by Uniphar PLC (LON: UPR) in 2021

Exit

Intact Vascular

Developer of peripheral vascular products acquired by Royal Philips (NYSE: PHG) in 2020

Exit

Mitralign

Developer of a transcatheter mitral and tricuspid valve repair technology acquired by Edwards (NYSE:EW) in 2019

Exit

Rebound Therapeutics

Developer of medical devices for MIS acquired by Integra Lifesciences (NASDAQ:IART) in 2019

Exit

Claret Medical

Cerebral Embolic Protection technology used during TAVR procedures, acquired by Boston Scientific (NYSE:BSX) in 2018

Exit

Essential Medical

Developer of femoral artery closure devices acquired by Teleflex (NYSE: TFX) in 2018

Exit

ImThera Medical

Neurostimulation device for Sleep Apnea acquired by LivaNova (NASDAQ:LVIN) in 2018

Exit

ReCor Medical

Ultrasound system for renal denervation acquired by Otsuka Holdings (TYO:4578) in 2018

Exit

Boston Heart Diagnostics

Provider of diagnostics services acquired by Eurofins Scientific(EURONEXT:ERF) in 2015

Exit

CardiAQ Valve Technologies

Percutaneous mitral heart valve replacement acquired by Edwards (NYSE: EW) in 2015

Exit

Loma Vista Medical

Developer of innovative balloon catheters to treat Aortic Stenosis, acquired by C.R.Bard (NYSE: BCR) in 2013, now part of BD

Exit

Atritech

Left atrial appendage system WATCHMAN acquired by Boston Scientific (NYSE: BSX) in 2011

Exit

Embrella Cardiovascular

Developer of Embolic Cerebral Protection system acquired by Edwards (NYSE: EW) in 2011

Exit

CoreValve

Transcatheter Aortic Valve Replacement device acquired by Medtronic (NYSE: MDT) in 2009

Exit

OVUM Ventures

Distributor of medical devices acquired by Medtronic (NYSE: MDT) in 2009

Exit

ArteriA

Technologies with applications in stroke diagnostics acquired by W.L.Gore in 2005

Exit

Micrus Endovascular

Implantable Medical Devices used in Cerebral Vascular Diseases - IPO (NASDAQ:MEND) in 2005

Exit

ACIST

Contrast imaging system technology for cardiology acquired by Bracco Group in 2001

Exit

Cardiologic

Distributor of medical devices acquired by Boston Scientific (NYSE: BSX) in 2001

Exit

Embolic Protection

System preventing embolic complications acquired by Boston Scientific (NYSE:BSX) in 2001

Exit

Vascular Solutions

Blood clotting products - IPO (NASDAQ: VASC) in 2001, now part of Teleflex (NYSE: TFX)

Exit

Endologix

Developer of aortic disorders treatment devices - IPO (NASDAQ: ELGX) in 2000

Exit

Vascular Science

Acquired by St. Jude Medical (NYSE:STJ) in 1999, now part of Abbott Laboratories (NYSE:ABT)

Exit